The global ATP monitoring consumables market size was valued at USD 66.0 million in 2024. The market is projected to grow from USD 68.9 million in 2025 to USD 97.7 million by 2032, exhibiting a CAGR of 5.1% during the forecast period.

Data Validated and Triangulated Final

ATP (adenosine triphosphate) monitoring devices are used to measure levels of ATP on a surface, and thus the cleanliness levels of a facility. The ATP system uses a hand-held device called a luminometer, which is combined with a sampling swab to identify the cleanliness of any surface in healthcare facilities.

The growth of the global ATP monitoring consumables market is driven by an increasing number of hospital-acquired infection cases and the increasing utilization of ATP detection products in healthcare facilities.

  • For example, as per the data provided by the Government of Canada in June 2024, the number of hospital-acquired Clostridioides difficile infection cases increased from 3,643 in 2021 to 3,846 in 2022.

Furthermore, the market comprises several small and mid-size companies such as Solventum, Hygiena LLC, Getinge, and Neogen Corporation. These key players are actively participating in medical conferences to create product awareness among consumers.

MARKET DYNAMICS
Market Drivers

High Incidence of Hospital-acquired Infections is Driving Market Growth

The rising cases of hospital-acquired infections (HAIs) are increasing the demand for ATP monitoring consumables in healthcare facilities. Common hospital-acquired infections (HAIs), including sepsis, catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia, and surgical site infections, are increasing substantially across the world, placing immense pressure on hospitals and specialty clinics to strengthen their hygiene protocols.

  • For example, as per the data provided by the Indian Journal of Critical Care Medicine in May 2025, a prospective cohort study was carried out at the Medical Intensive Unit of a tertiary care teaching medical institute from October 2022 to April 2023. The total number of catheterizations in the study period was 1,304, out of which 148 developed CAUTI, indicating a CAUTI incidence rate of 11.35%.

The ATP monitoring products provide an effective method for assessing cleanliness by detecting harmful pathogens, such as Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis. This increases demand for ATP monitoring products and related consumables such as swabs and reagents, particularly for validating the cleanliness of surgical equipment and rooms.

Growing Emphasis from Regulatory Authorities to Mandate Sterilization in Healthcare Facilities to Augment Market Growth

The increasing emphasis by regulatory authorities on mandating sterilization protocols in healthcare settings is one of the important factors driving market growth. Government regulations such as the U.S. Food and Drug Administration (FDA), International Organisation for Standardisation (ISO), and others have made hygiene verification mandatory across several healthcare sectors, thereby reinforcing the need for ATP consumables.

As infection control becomes a top priority, particularly in the case of hospital-acquired infections, the government authorities of respective countries are implementing standard sterilization protocols to ensure patients’ safety.

Over the past few years, ATP monitoring products have been recognized as a reliable and effective tool for assessing cleanliness and contamination in surgical rooms, ICUs, and equipment sterilization areas. Healthcare settings are adopting consumables such as swabs, reagents, and others to meet the regulatory requirements. These factors are collectively driving the ATP monitoring consumables market growth.

Market Restraints

Lack of Skilled Professionals in Developing Countries Restricts Market Growth

The developing nations, which lack trained and skilled professionals capable of effectively using and interpreting ATP monitoring systems, are hindering market growth. Although designed for rapid hygiene monitoring, these systems require a basic knowledge of equipment calibration, microbiology, swabbing technique, and data interpretation to ensure accurate results.

Several developing countries, especially the resource-constrained settings, have a shortage of trained microbiologists and quality assurance personnel. In addition, when facilities invest in ATP monitoring devices, they face challenges in maintaining and operating them due to a lack of skilled personnel.

Limited Awareness about Effective Sterilization in Emerging Nations Hinders Market Growth

The limited awareness and ignorance of sterilization standards among healthcare facilities in low-income countries further hampers the demand for ATP monitoring products, which are used to verify the effectiveness of cleaning processes before sterilization. For instance, as per the data published by the National Centers for Biotechnology Information (NCBI) in November 2023, in India, out of every 100 patients admitted to the hospitals, at least 15 have a chance to develop hospital-acquired infection (HAI).

Market Opportunities

Expansion of Pharmaceutical and Medical Devices Manufacturing in Developing Nations Creating Opportunities for Market Growth

The rapid growth of pharmaceutical, biopharmaceutical, and medical device manufacturing in developing nations such as India, China, and Brazil creates a significant opportunity for market growth. As these sectors expand, they must follow stringent regulatory standards for cleanliness and contamination control, in line with international guidelines such as Good Manufacturing Practices (GMP). Additionally, the increasing focus of pharmaceutical and medical device companies on expanding their manufacturing capacity is expected to create growth opportunities for market players.

  • For example, in November 2024, Abbott announced the opening of its manufacturing facility in Kilkenny, Ireland. This globally capable site was established to enhance the manufacturing of various treatment products.

The ATP monitoring offers a fast and reliable method for verifying cleanliness in the manufacturing areas. With rising manufacturing activities, the need for frequent hygiene verification also increases, resulting in the increased usage of ATP monitoring solutions.

Market Challenges

High Cost of ATP Monitoring Consumables to Limit Their Adoption in Low-income Countries

The high cost of ATP monitoring products represents a substantial barrier to widespread adoption in low-income nations. The ATP monitoring devices require frequent purchasing of consumables, such as swabs, reagents, and others. Moreover, many of these products are priced to align with the standards of nations with advanced healthcare infrastructure, making them inaccessible for healthcare settings in low-income countries. Furthermore, the low-income countries have limited budgets for healthcare spending, limiting the adoption of ATP monitoring products and related consumables.

  • For example, the cost of the 3M Clean-Trace Surface ATP Test Swab UXL100 is USD 429.8, while a pack of 100 Hygiena Ultrasnap surface ATP swabs costs around USD 756.50.

Thus, the high cost of consumables limits the scalability of ATP monitoring products in low-income countries. This poses a significant market challenge for manufacturers aiming to expand their footprints globally.

Availability of Other Sterilization Validation Products to Pose Significant Market Challenge

The availability of other sterilization validation products, such as biological indicators, chemical indicators, and indicator tapes, may limit the adoption of ATP monitoring consumables, thereby hindering market growth.

Biological indicators are considered the gold standard for sterilization validation as they directly test the sterilization process’s effectiveness using highly resistant microbial spores. Also, the biological indicators confirm the killing of microorganisms, which ATP monitoring consumables cannot. Market players are increasingly focusing on the launch of biological indicators to validate the sterilization process. For example, in December 2020, STERIS announced the global launch of Spordex self-contained biological indicator (SCBI) ampoules to confirm sterilization of liquids in steam autoclave cycles.                                                         

Furthermore, the chemical indicators are cheaper than ATP monitoring consumables, increasing their adoption in low-income countries.

Request a Free sample to learn more about this report.

ATP MONITORING CONSUMABLES MARKET TRENDS

Integration of ATP Monitoring Products with Digital Platforms to Spur Market Development

Integrating ATP monitoring systems with digital platforms is a key market trend that significantly transforms hygiene and contamination control methods. This trend enhances the efficiency and accuracy of monitoring processes and increases the usage of ATP consumables. As a result, various healthcare sectors are adopting ATP monitoring products, contributing to overall market growth.

  • For example, in June 2024, Tianlong, an innovative R&D company specializing in molecular diagnostic products, demonstrated its dedication to environmental sustainability and cleanliness by introducing the Biolum Pro ATP hygiene monitoring system series. This next-generation hygiene monitoring system generates results in just 10 seconds. The intuitive smartphone design with a 5-inch touch-shatter-proof screen ensures user-friendly operation. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever.

SEGMENTATION ANALYSIS
By Product

Increasing Launch of Swabs to Perform ATP Monitoring Boosted Segment Growth

Based on product, the market is divided into swabs, reagents, and others.

The swabs segment dominated the global market in 2024 and is expected to grow at the highest CAGR during the forecast period. One of the key factors driving this growth is the increasing market players’ focus on the launch of ATP monitoring swabs to ensure the cleanliness of the surfaces in the healthcare setting. For example, in May 2024, GuangDong Dayuan & Oasis FoodTech Ltd. announced the launch of the Surface ATP test swab in the global market.

The reagents segment accounted for a moderate market share in 2024 and is anticipated to grow at a moderate CAGR during the forecast period, owing to increasing utilization of ATP monitoring reagents by pharma and medical device industries in the sterilization process.

By Sterilization Method

Steam Sterilization Segment Dominated Due to Its High Adoption at Healthcare Facilities

In terms of sterilization method, the market is segmented into steam sterilization, hydrogen peroxide sterilization, ethylene oxide sterilization, and others.

The steam sterilization segment held a dominant global ATP monitoring consumables market share in 2024 and is estimated to grow at the second-largest CAGR from 2025-2032. The segment’s growth is attributed to the rising adoption of steam sterilizers at healthcare facilities.

  • For example, in June 2023, idsMED Taiwan installed Steelco steam sterilizers at the Ministry of Health and Welfare Taipei Hospital in New Taipei City, Taiwan. This initiative aimed to enhance sterilization capabilities and ensure top-tier patient care and safety.

The hydrogen peroxide sterilization segment accounted for the second-largest market share in 2024 and is estimated to grow at the highest CAGR from 2025-2032. The rising adoption of the hydrogen peroxide sterilization method by manufacturers and service providers for effective sterilization of pharmaceuticals and medical devices is one of the major factors augmenting the segment’s growth.

  • For example, in June 2020, STERIS Applied Sterilization Technologies (AST) started providing vaporized hydrogen peroxide (VHP) sterilization services in its Tullamore, Ireland, facility as part of its contract sterilization offering.

The others segment is anticipated to grow at a stagnant CAGR during the forecast period. Opening new sterilization facilities and expanding existing sterilization services facilities, including ionizing sterilization, are important factors driving the segment’s growth.

  • For example, in June 2024, STERIS completed the expansion of its existing facility, the Illinois gamma processing facility, to include x-ray processing.

  • In April 2024, STERIS announced the expansion of its existing Suzhou, China EO processing facility to include X-ray processing. In addition to the Suzhou, China facility, STERIS supports medical device manufacturing in Asia through its electron beam, ethylene oxide, gamma, and X-ray processing sterilization services in Malaysia and Thailand.

By End-user

Hospital & Clinics Segment Dominated Market Due to the Opening of New Advanced Sterilization Facilities

In terms of end user, the market is segmented into hospitals & clinics, pharmaceutical & medical device manufacturers, and others.

The hospitals & clinics segment dominated the global market in 2024 and is expected to grow at the highest CAGR from 2025 to 2032, owing to the opening of new sterilization facilities providing sterilization services to hospitals and clinics globally. For instance, in March 2023, Servizi Italia Spa announced the inauguration of its first sterilization plant in São Paulo, Brazil. This facility provides steam sterilization services to the São Paulo, Brazil, hospitals.

The pharmaceutical & medical device manufacturers segment is expected to grow moderately during the forecast period. The growing demand for ATP monitoring products by the pharmaceutical and medical device industries for pharmaceutical and medical device manufacturing is driving the segment’s growth. Additionally, opening new pharmaceutical and medical device manufacturing facilities further supplements segment growth.

  • For example, in April 2025, SCHOTT Pharma inaugurated a new manufacturing facility in central Serbia to enhance the production of glass ampoules.

The others segment is expected to grow at a stagnant CAGR throughout the forecast period, owing to increasing usage of ATP monitoring consumables by academic and research institutes to assess the cleanliness of surfaces while performing research activities.

ATP MONITORING CONSUMABLES MARKET REGIONAL OUTLOOK

In terms of region, the global market can be divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America ATP Monitoring Consumables Market Size, 2024 (USD Million)

To get more information on the regional analysis of this market, Request a Free sample

North America accounted for a market size of USD 30.6 million in 2024 and dominated the market with a share of 46.3%. The region’s market growth is attributed to the presence of advanced healthcare infrastructure and a large number of market players providing ATP monitoring products and related consumables.

Furthermore, the high burden of hospital-acquired infections in the U.S. has led to an increase in demand for ATP monitoring products in healthcare facilities, fueling market growth in the U.S.

  • For example, as per the data provided by the Centers for Disease Control and Prevention (CDC) in January 2024, around 30,100 central line-associated bloodstream infections (CLABSI) occur in intensive care units and wards in the U.S. every year.

Europe

Europe accounted for the second-largest share of the market in 2024 and is anticipated to grow at the second-largest CAGR during the forecast period. The increasing market players’ focus on participating in medical conferences to create awareness about medical products and related consumables among healthcare professionals is one of the important factors driving market growth across Europe.

  • For example, in May 2025, Terragene announced that its partner, Creatus, participated in the XXXII Congress of the Polish Association of Medical Sterilization conference in Nałęczów, Poland.

Asia Pacific

Asia Pacific held a moderate market share in 2024 and is anticipated to grow at the highest CAGR throughout the forecast period. The increasing market players’ focus on expanding their footprints in this region by opening new facilities is one of the main factors driving market growth in this region.

  • For example, in September 2023, Hygiena LLC, the global manufacturer and supplier of rapid microbial detection, monitoring, and identification, announced the inauguration of its new branch in Sydney, Australia.

Latin America and Middle East & Africa

The ATP monitoring consumables market in Latin America and the Middle East & Africa is expected to grow at a considerable CAGR throughout the forecast period. The increasing market players’ focus on creating awareness about sterilization solutions, including ATP monitoring products among healthcare professionals, is enhancing market growth in these regions.

  • For example, in November 2024, Terragene participated in the 25th WFHSS Congress held in Santiago, Chile. The company showcased its sterilization consumables during the event to create product awareness among healthcare professionals.

COMPETITIVE LANDSCAPE
Key Industry Players

Market Players Focus on Participating in Medical Conferences to Create Product Awareness among Consumers

The market is fragmented with the presence of several small and mid-sized companies. The market comprises major players, such as Solventum, Hygiena LLC, Getinge, and Terragene. These companies hold a substantial proportion of the market due to their strong focus on attending medical conferences to create brand awareness among consumers.

  • For example, in April 2025, Terragene participated in INTERPHEX 2025, held in New York, U.S. During the event, the company showcased its sterilization products, including ATP monitoring consumables, to enhance its brand image in the global market.

Moreover, other players in the market include Neogen Corporation, NEMIS Technologies AG, Ruhof, and Meizheng. These companies have been focusing on new product launches to enhance their portfolio and expand their footprint in the global market.

List of Key ATP Monitoring Consumable Companies Profiled

  • Solventum (U.S.)

  • Hygiena LLC (U.S.)

  • Getinge (Sweden)

  • NEMIS Technologies AG (Switzerland)

  • Neogen Corporation (U.S.)

  • GuangDong Dayuan & Oasis FoodTech Ltd. (China)

  • Ruhof (U.S.)

  • Terragene (Argentina)

  • Meizheng (China)

  • Kikkoman Corporation (Japan)

  • Charm Sciences (U.S.)

KEY INDUSTRY DEVELOPMENTS

  • January 2025 – Terragene participated in Arab Health 2025, an event held in Dubai, UAE. During the event, the company showcased its hygiene monitoring products to create awareness among the healthcare professionals.

  • September 2024 – Hygiena LLC entered into a partnership with DKSH Holding Ltd. As per this agreement, DKSH started providing comprehensive market analysis, marketing, sales, distribution, and after-sales services, ensuring Hygiena’s cutting-edge products reach key industries in Cambodia, Laos, and Myanmar.

  • August 2024 – Kikkoman Corporation participated in the 26th Central Sterilizing Services Association. This event was held in Nonthaburi, Thailand, from 26th to 28th August 2024. During the event company showcased its ATP monitoring products to create brand awareness among consumers.

  • November 2022 – Hygiena LLC, a manufacturer and supplier of hygiene monitoring and microbial detection products, opened a new branch in São Paulo, Brazil.

  • May 2021 – Neogen Corporation launched an improved version of its AccuPoint advanced sanitation monitoring system that is simpler to use and provides results that are easier to analyze. Neogen’s new AccuPoint Advanced Next Generation (NG) system utilizes a flat tip sampler for maximized recovery of ATP (adenosine triphosphate) and features RFID technology for streamlined testing processes.

REPORT COVERAGE

The global ATP monitoring consumables market report provides a detailed competitive landscape and market insights. In addition to the market size, it covers regional analysis of different market segments, profiles of key market players, and market dynamics. Moreover, the market report encompasses several factors contributing to the market’s growth over recent years.

To gain extensive insights into the market, Request for Customization

REPORT SCOPE & SEGMENTATION

ATTRIBUTE 

DETAILS


Study Period

2019-2032


Base Year

2024


Estimated Year 

2025


Forecast Period

2025-2032


Historical Period

2019-2023


Growth Rate

CAGR of 5.1% from 2025-2032


Unit

Value (USD million)


Segmentation

By Sterilization Method

  • Steam Sterilization

  • Hydrogen Peroxide Sterilization

  • Ethylene Oxide Sterilization

  • Others


By End-user

  • Hospital & Clinics

  • Pharmaceutical & Medical Device Manufacturers

  • Others


By Region

  • North America (By Product, By Sterilization Method, By End-user, and By Country)


  • Europe (By Product, By Sterilization Method, By End-user, and By Country/Sub-Region)

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Scandinavia

    • Rest of Europe

  • Asia Pacific (By Product, By Sterilization Method, By End-user, and By Country/Sub-Region)

    • China

    • Japan

    • India

    • Australia

    • Southeast Asia

    • Rest of Asia Pacific

  • Latin America (By Product, By Sterilization Method, By End-user, and By Country/Sub-Region)

    • Brazil

    • Mexico

    • Rest of Latin America

  • Middle East & Africa (By Product, By Sterilization Method, By End-user, and By Country/Sub-Region)

    • GCC

    • South Africa

    • Rest of Middle East & Africa